Global Biosimilars Sales Market Report 2021

Global Biosimilars Sales Market Report 2021

Table of Contents
1 Biosimilars Market Overview
1.1 Biosimilars Product Scope
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Biosimilars Segment by Application
1.3.1 Global Biosimilars Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Biosimilars Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biosimilars Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biosimilars Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biosimilars Price Trends (2016-2027)
2 Biosimilars Estimates and Forecasts by Region
2.1 Global Biosimilars Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biosimilars Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biosimilars Sales Market Share by Region (2016-2021)
2.2.2 Global Biosimilars Revenue Market Share by Region (2016-2021)
2.3 Global Biosimilars Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biosimilars Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biosimilars Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biosimilars Estimates and Projections (2016-2027)
2.4.2 Europe Biosimilars Estimates and Projections (2016-2027)
2.4.3 China Biosimilars Estimates and Projections (2016-2027)
2.4.4 Japan Biosimilars Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biosimilars Estimates and Projections (2016-2027)
2.4.6 India Biosimilars Estimates and Projections (2016-2027)
3 Global Biosimilars Competition Landscape by Players
3.1 Global Top Biosimilars Players by Sales (2016-2021)
3.2 Global Top Biosimilars Players by Revenue (2016-2021)
3.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars as of 2020)
3.4 Global Biosimilars Average Price by Company (2016-2021)
3.5 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biosimilars Market Size by Type
4.1 Global Biosimilars Historic Market Review by Type (2016-2021)
4.1.1 Global Biosimilars Sales Market Share by Type (2016-2021)
4.1.2 Global Biosimilars Revenue Market Share by Type (2016-2021)
4.1.3 Global Biosimilars Price by Type (2016-2021)
4.2 Global Biosimilars Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biosimilars Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilars Revenue Forecast by Type (2022-2027)
4.2.3 Global Biosimilars Price Forecast by Type (2022-2027)
5 Global Biosimilars Market Size by Application
5.1 Global Biosimilars Historic Market Review by Application (2016-2021)
5.1.1 Global Biosimilars Sales Market Share by Application (2016-2021)
5.1.2 Global Biosimilars Revenue Market Share by Application (2016-2021)
5.1.3 Global Biosimilars Price by Application (2016-2021)
5.2 Global Biosimilars Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biosimilars Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilars Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilars Price Forecast by Application (2022-2027)
6 North America Biosimilars Market Facts & Figures
6.1 North America Biosimilars Sales by Company
6.1.1 North America Biosimilars Sales by Company (2016-2021)
6.1.2 North America Biosimilars Revenue by Company (2016-2021)
6.2 North America Biosimilars Sales Breakdown by Type
6.2.1 North America Biosimilars Sales Breakdown by Type (2016-2021)
6.2.2 North America Biosimilars Sales Breakdown by Type (2022-2027)
6.3 North America Biosimilars Sales Breakdown by Application
6.3.1 North America Biosimilars Sales Breakdown by Application (2016-2021)
6.3.2 North America Biosimilars Sales Breakdown by Application (2022-2027)
7 Europe Biosimilars Market Facts & Figures
7.1 Europe Biosimilars Sales by Company
7.1.1 Europe Biosimilars Sales by Company (2016-2021)
7.1.2 Europe Biosimilars Revenue by Company (2016-2021)
7.2 Europe Biosimilars Sales Breakdown by Type
7.2.1 Europe Biosimilars Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biosimilars Sales Breakdown by Type (2022-2027)
7.3 Europe Biosimilars Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Biosimilars Market Facts & Figures
8.1 China Biosimilars Sales by Company
8.1.1 China Biosimilars Sales by Company (2016-2021)
8.1.2 China Biosimilars Revenue by Company (2016-2021)
8.2 China Biosimilars Sales Breakdown by Type
8.2.1 China Biosimilars Sales Breakdown by Type (2016-2021)
8.2.2 China Biosimilars Sales Breakdown by Type (2022-2027)
8.3 China Biosimilars Sales Breakdown by Application
8.3.1 China 174 Sales Breakdown by Application (2016-2021)
8.3.2 China 174 Sales Breakdown by Application (2022-2027)
9 Japan Biosimilars Market Facts & Figures
9.1 Japan Biosimilars Sales by Company
9.1.1 Japan Biosimilars Sales by Company (2016-2021)
9.1.2 Japan Biosimilars Revenue by Company (2016-2021)
9.2 Japan Biosimilars Sales Breakdown by Type
9.2.1 Japan Biosimilars Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biosimilars Sales Breakdown by Type (2022-2027)
9.3 Japan Biosimilars Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biosimilars Market Facts & Figures
10.1 Southeast Asia Biosimilars Sales by Company
10.1.1 Southeast Asia Biosimilars Sales by Company (2016-2021)
10.1.2 Southeast Asia Biosimilars Revenue by Company (2016-2021)
10.2 Southeast Asia Biosimilars Sales Breakdown by Type
10.2.1 Southeast Asia Biosimilars Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biosimilars Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biosimilars Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Biosimilars Market Facts & Figures
11.1 India Biosimilars Sales by Company
11.1.1 India Biosimilars Sales by Company (2016-2021)
11.1.2 India Biosimilars Revenue by Company (2016-2021)
11.2 India Biosimilars Sales Breakdown by Type
11.2.1 India Biosimilars Sales Breakdown by Type (2016-2021)
11.2.2 India Biosimilars Sales Breakdown by Type (2022-2027)
11.3 India Biosimilars Sales Breakdown by Application
11.3.1 India Biosimilars Sales Breakdown by Application (2016-2021)
11.3.2 India Biosimilars Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biosimilars Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Biosimilars Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Biosimilars Products Offered
12.2.5 Novartis Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Business Overview
12.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Biosimilars Products Offered
12.3.5 Biocon Recent Development
12.4 Biogen
12.4.1 Biogen Corporation Information
12.4.2 Biogen Business Overview
12.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biogen Biosimilars Products Offered
12.4.5 Biogen Recent Development
12.5 Fresenius Kabi AG
12.5.1 Fresenius Kabi AG Corporation Information
12.5.2 Fresenius Kabi AG Business Overview
12.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fresenius Kabi AG Biosimilars Products Offered
12.5.5 Fresenius Kabi AG Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer Ingelheim Biosimilars Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Merck KgaA
12.7.1 Merck KgaA Corporation Information
12.7.2 Merck KgaA Business Overview
12.7.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck KgaA Biosimilars Products Offered
12.7.5 Merck KgaA Recent Development
12.8 Mylan
12.8.1 Mylan Corporation Information
12.8.2 Mylan Business Overview
12.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mylan Biosimilars Products Offered
12.8.5 Mylan Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Biosimilars Products Offered
12.9.5 Eli Lilly Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Corporation Information
12.10.2 Teva Pharmaceutical Business Overview
12.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Biosimilars Products Offered
12.10.5 Teva Pharmaceutical Recent Development
12.11 Dr. Reddy's Laboratories
12.11.1 Dr. Reddy's Laboratories Corporation Information
12.11.2 Dr. Reddy's Laboratories Business Overview
12.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Dr. Reddy's Laboratories Biosimilars Products Offered
12.11.5 Dr. Reddy's Laboratories Recent Development
12.12 Amgen
12.12.1 Amgen Corporation Information
12.12.2 Amgen Business Overview
12.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Amgen Biosimilars Products Offered
12.12.5 Amgen Recent Development
12.13 Celltrion
12.13.1 Celltrion Corporation Information
12.13.2 Celltrion Business Overview
12.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Celltrion Biosimilars Products Offered
12.13.5 Celltrion Recent Development
12.14 Samsung Biologics
12.14.1 Samsung Biologics Corporation Information
12.14.2 Samsung Biologics Business Overview
12.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Samsung Biologics Biosimilars Products Offered
12.14.5 Samsung Biologics Recent Development
12.15 Roche
12.15.1 Roche Corporation Information
12.15.2 Roche Business Overview
12.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Roche Biosimilars Products Offered
12.15.5 Roche Recent Development
12.16 Probiomed
12.16.1 Probiomed Corporation Information
12.16.2 Probiomed Business Overview
12.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Probiomed Biosimilars Products Offered
12.16.5 Probiomed Recent Development
12.17 Apotex
12.17.1 Apotex Corporation Information
12.17.2 Apotex Business Overview
12.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Apotex Biosimilars Products Offered
12.17.5 Apotex Recent Development
12.18 Chong Kun Dang
12.18.1 Chong Kun Dang Corporation Information
12.18.2 Chong Kun Dang Business Overview
12.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Chong Kun Dang Biosimilars Products Offered
12.18.5 Chong Kun Dang Recent Development
12.19 JCR Pharmaceuticals
12.19.1 JCR Pharmaceuticals Corporation Information
12.19.2 JCR Pharmaceuticals Business Overview
12.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.19.4 JCR Pharmaceuticals Biosimilars Products Offered
12.19.5 JCR Pharmaceuticals Recent Development
12.20 Gan & Lee Pharmaceuticals
12.20.1 Gan & Lee Pharmaceuticals Corporation Information
12.20.2 Gan & Lee Pharmaceuticals Business Overview
12.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Gan & Lee Pharmaceuticals Biosimilars Products Offered
12.20.5 Gan & Lee Pharmaceuticals Recent Development
12.21 Gedeon Richter
12.21.1 Gedeon Richter Corporation Information
12.21.2 Gedeon Richter Business Overview
12.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Gedeon Richter Biosimilars Products Offered
12.21.5 Gedeon Richter Recent Development
12.22 Biocad
12.22.1 Biocad Corporation Information
12.22.2 Biocad Business Overview
12.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Biocad Biosimilars Products Offered
12.22.5 Biocad Recent Development
12.23 Coherus Bioscience
12.23.1 Coherus Bioscience Corporation Information
12.23.2 Coherus Bioscience Business Overview
12.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Coherus Bioscience Biosimilars Products Offered
12.23.5 Coherus Bioscience Recent Development
12.24 Stada Arzneimittel AG
12.24.1 Stada Arzneimittel AG Corporation Information
12.24.2 Stada Arzneimittel AG Business Overview
12.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Stada Arzneimittel AG Biosimilars Products Offered
12.24.5 Stada Arzneimittel AG Recent Development
13 Biosimilars Manufacturing Cost Analysis
13.1 Biosimilars Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilars
13.4 Biosimilars Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilars Distributors List
14.3 Biosimilars Customers
15 Market Dynamics
15.1 Biosimilars Market Trends
15.2 Biosimilars Drivers
15.3 Biosimilars Market Challenges
15.4 Biosimilars Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Biosimilars Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Biosimilars Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Biosimilars Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Biosimilars Sales (K MT) by Region (2016-2021)
Table 5. Global Biosimilars Sales Market Share by Region (2016-2021)
Table 6. Global Biosimilars Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Biosimilars Revenue Share by Region (2016-2021)
Table 8. Global Biosimilars Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Biosimilars Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Biosimilars Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Biosimilars Revenue Share Forecast by Region (2022-2027)
Table 12. Global Biosimilars Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Biosimilars Sales Share by Company (2016-2021)
Table 14. Global Biosimilars Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Biosimilars Revenue Share by Company (2016-2021)
Table 16. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2020)
Table 17. Global Biosimilars Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Biosimilars Manufacturing Sites and Area Served
Table 19. Manufacturers Biosimilars Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Biosimilars Sales (K MT) by Type (2016-2021)
Table 22. Global Biosimilars Sales Share by Type (2016-2021)
Table 23. Global Biosimilars Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Biosimilars Price (USD/MT) by Type (2016-2021)
Table 25. Global Biosimilars Sales Share by Type (2022-2027)
Table 26. Global Biosimilars Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Biosimilars Revenue Share by Type (2022-2027)
Table 28. Global Biosimilars Price (USD/MT) by Type (2022-2027)
Table 29. Global Biosimilars Sales (K MT) by Application (2016-2021)
Table 30. Global Biosimilars Sales Share by Application (2016-2021)
Table 31. Global Biosimilars Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Biosimilars Price (USD/MT) by Application (2016-2021)
Table 33. Global Biosimilars Sales (K MT) by Application (2022-2027)
Table 34. Global Biosimilars Sales Share by Application (2022-2027)
Table 35. Global Biosimilars Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Biosimilars Revenue Share by Application (2022-2027)
Table 37. Global Biosimilars Price (USD/MT) by Application (2022-2027)
Table 38. North America Biosimilars Sales (K MT) by Company (2016-2021)
Table 39. North America Biosimilars Sales Market Share by Company (2016-2021)
Table 40. North America Biosimilars Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Biosimilars Revenue Market Share by Company (2016-2021)
Table 42. North America Biosimilars Sales by Type (2016-2021) & (K MT)
Table 43. North America Biosimilars Sales Market Share by Type (2016-2021)
Table 44. North America Biosimilars Sales by Type (2022-2027) & (K MT)
Table 45. North America Biosimilars Sales Market Share by Type (2022-2027)
Table 46. North America Biosimilars Sales by Application (2016-2021) & (K MT)
Table 47. North America Biosimilars Sales Market Share by Application (2016-2021)
Table 48. North America Biosimilars Sales by Application (2022-2027) & (K MT)
Table 49. North America Biosimilars Sales Market Share by Application (2022-2027)
Table 50. Europe Biosimilars Sales (K MT) by Company (2016-2021)
Table 51. Europe Biosimilars Sales Market Share by Company (2016-2021)
Table 52. Europe Biosimilars Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Biosimilars Revenue Market Share by Company (2016-2021)
Table 54. Europe Biosimilars Sales by Type (2016-2021) & (K MT)
Table 55. Europe Biosimilars Sales Market Share by Type (2016-2021)
Table 56. Europe Biosimilars Sales by Type (2022-2027) & (K MT)
Table 57. Europe Biosimilars Sales Market Share by Type (2022-2027)
Table 58. Europe Biosimilars Sales by Application (2016-2021) & (K MT)
Table 59. Europe Biosimilars Sales Market Share by Application (2016-2021)
Table 60. Europe Biosimilars Sales by Application (2022-2027) & (K MT)
Table 61. Europe Biosimilars Sales Market Share by Application (2022-2027)
Table 62. China Biosimilars Sales (K MT) by Company (2016-2021)
Table 63. China Biosimilars Sales Market Share by Company (2016-2021)
Table 64. China Biosimilars Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Biosimilars Revenue Market Share by Company (2016-2021)
Table 66. China Biosimilars Sales by Type (2016-2021) & (K MT)
Table 67. China Biosimilars Sales Market Share by Type (2016-2021)
Table 68. China Biosimilars Sales by Type (2022-2027) & (K MT)
Table 69. China Biosimilars Sales Market Share by Type (2022-2027)
Table 70. China Biosimilars Sales by Application (2016-2021) & (K MT)
Table 71. China Biosimilars Sales Market Share by Application (2016-2021)
Table 72. China Biosimilars Sales by Application (2022-2027) & (K MT)
Table 73. China Biosimilars Sales Market Share by Application (2022-2027)
Table 74. Japan Biosimilars Sales (K MT) by Company (2016-2021)
Table 75. Japan Biosimilars Sales Market Share by Company (2016-2021)
Table 76. Japan Biosimilars Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Biosimilars Revenue Market Share by Company (2016-2021)
Table 78. Japan Biosimilars Sales by Type (2016-2021) & (K MT)
Table 79. Japan Biosimilars Sales Market Share by Type (2016-2021)
Table 80. Japan Biosimilars Sales by Type (2022-2027) & (K MT)
Table 81. Japan Biosimilars Sales Market Share by Type (2022-2027)
Table 82. Japan Biosimilars Sales by Application (2016-2021) & (K MT)
Table 83. Japan Biosimilars Sales Market Share by Application (2016-2021)
Table 84. Japan Biosimilars Sales by Application (2022-2027) & (K MT)
Table 85. Japan Biosimilars Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Biosimilars Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Biosimilars Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Biosimilars Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Biosimilars Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Biosimilars Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Biosimilars Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Biosimilars Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Biosimilars Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Biosimilars Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Biosimilars Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Biosimilars Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Biosimilars Sales Market Share by Application (2022-2027)
Table 98. India Biosimilars Sales (K MT) by Company (2016-2021)
Table 99. India Biosimilars Sales Market Share by Company (2016-2021)
Table 100. India Biosimilars Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Biosimilars Revenue Market Share by Company (2016-2021)
Table 102. India Biosimilars Sales by Type (2016-2021) & (K MT)
Table 103. India Biosimilars Sales Market Share by Type (2016-2021)
Table 104. India Biosimilars Sales by Type (2022-2027) & (K MT)
Table 105. India Biosimilars Sales Market Share by Type (2022-2027)
Table 106. India Biosimilars Sales by Application (2016-2021) & (K MT)
Table 107. India Biosimilars Sales Market Share by Application (2016-2021)
Table 108. India Biosimilars Sales by Application (2022-2027) & (K MT)
Table 109. India Biosimilars Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Pfizer Biosimilars Product
Table 114. Pfizer Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Novartis Biosimilars Product
Table 119. Novartis Recent Development
Table 120. Biocon Corporation Information
Table 121. Biocon Description and Business Overview
Table 122. Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Biocon Biosimilars Product
Table 124. Biocon Recent Development
Table 125. Biogen Corporation Information
Table 126. Biogen Description and Business Overview
Table 127. Biogen Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Biogen Biosimilars Product
Table 129. Biogen Recent Development
Table 130. Fresenius Kabi AG Corporation Information
Table 131. Fresenius Kabi AG Description and Business Overview
Table 132. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Fresenius Kabi AG Biosimilars Product
Table 134. Fresenius Kabi AG Recent Development
Table 135. Boehringer Ingelheim Corporation Information
Table 136. Boehringer Ingelheim Description and Business Overview
Table 137. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Boehringer Ingelheim Biosimilars Product
Table 139. Boehringer Ingelheim Recent Development
Table 140. Merck KgaA Corporation Information
Table 141. Merck KgaA Description and Business Overview
Table 142. Merck KgaA Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Merck KgaA Biosimilars Product
Table 144. Merck KgaA Recent Development
Table 145. Mylan Corporation Information
Table 146. Mylan Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Mylan Description and Business Overview
Table 148. Mylan Biosimilars Product
Table 149. Mylan Recent Development
Table 150. Eli Lilly Corporation Information
Table 151. Eli Lilly Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Eli Lilly Description and Business Overview
Table 153. Eli Lilly Biosimilars Product
Table 154. Eli Lilly Recent Development
Table 155. Teva Pharmaceutical Corporation Information
Table 156. Teva Pharmaceutical Description and Business Overview
Table 157. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Teva Pharmaceutical Biosimilars Product
Table 159. Teva Pharmaceutical Recent Development
Table 160. Dr. Reddy's Laboratories Corporation Information
Table 161. Dr. Reddy's Laboratories Description and Business Overview
Table 162. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Dr. Reddy's Laboratories Biosimilars Product
Table 164. Dr. Reddy's Laboratories Recent Development
Table 165. Amgen Corporation Information
Table 166. Amgen Description and Business Overview
Table 167. Amgen Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Amgen Biosimilars Product
Table 169. Amgen Recent Development
Table 170. Celltrion Corporation Information
Table 171. Celltrion Description and Business Overview
Table 172. Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Celltrion Biosimilars Product
Table 174. Celltrion Recent Development
Table 175. Samsung Biologics Corporation Information
Table 176. Samsung Biologics Description and Business Overview
Table 177. Samsung Biologics Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Samsung Biologics Biosimilars Product
Table 179. Samsung Biologics Recent Development
Table 180. Roche Corporation Information
Table 181. Roche Description and Business Overview
Table 182. Roche Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Roche Biosimilars Product
Table 184. Roche Recent Development
Table 185. Probiomed Corporation Information
Table 186. Probiomed Description and Business Overview
Table 187. Probiomed Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Probiomed Biosimilars Product
Table 189. Probiomed Recent Development
Table 190. Apotex Corporation Information
Table 191. Apotex Description and Business Overview
Table 192. Apotex Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Apotex Biosimilars Product
Table 194. Apotex Recent Development
Table 195. Chong Kun Dang Corporation Information
Table 196. Chong Kun Dang Description and Business Overview
Table 197. Chong Kun Dang Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Chong Kun Dang Biosimilars Product
Table 199. Chong Kun Dang Recent Development
Table 200. JCR Pharmaceuticals Corporation Information
Table 201. JCR Pharmaceuticals Description and Business Overview
Table 202. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. JCR Pharmaceuticals Biosimilars Product
Table 204. JCR Pharmaceuticals Recent Development
Table 205. Gan & Lee Pharmaceuticals Corporation Information
Table 206. Gan & Lee Pharmaceuticals Description and Business Overview
Table 207. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 208. Gan & Lee Pharmaceuticals Biosimilars Product
Table 209. Gan & Lee Pharmaceuticals Recent Development
Table 210. Gedeon Richter Corporation Information
Table 211. Gedeon Richter Description and Business Overview
Table 212. Gedeon Richter Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 213. Gedeon Richter Biosimilars Product
Table 214. Gedeon Richter Recent Development
Table 215. Biocad Corporation Information
Table 216. Biocad Description and Business Overview
Table 217. Biocad Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 218. Biocad Biosimilars Product
Table 219. Biocad Recent Development
Table 220. Coherus Bioscience Corporation Information
Table 221. Coherus Bioscience Description and Business Overview
Table 222. Coherus Bioscience Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 223. Coherus Bioscience Biosimilars Product
Table 224. Coherus Bioscience Recent Development
Table 225. Stada Arzneimittel AG Corporation Information
Table 226. Stada Arzneimittel AG Description and Business Overview
Table 227. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Ta

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs